A detailed history of Accent Capital Management, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Accent Capital Management, LLC holds 1,000 shares of BLUE stock, worth $350. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,700 41.18%
Holding current value
$350
Previous $1.67 Million 68.92%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$0.47 - $1.35 $329 - $945
-700 Reduced 41.18%
1,000 $520,000
Q1 2024

May 13, 2024

SELL
$0.91 - $1.75 $1,501 - $2,887
-1,650 Reduced 49.25%
1,700 $2.18 Million
Q4 2023

Mar 19, 2024

BUY
$1.32 - $4.83 $4,422 - $16,180
3,350 New
3,350 $4.62 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Accent Capital Management, LLC Portfolio

Follow Accent Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accent Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accent Capital Management, LLC with notifications on news.